Detalhe da pesquisa
1.
A picture is worth a thousand words: a history of diagnostic imaging for lymphoma.
Br J Radiol
; 94(1127): 20210285, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111961
2.
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Clin Cancer Res
; 14(23): 7878-83, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047117
3.
False-positive findings on 18F-FDG PET/CT: differentiation of hibernoma and malignant fatty tumor on the basis of fluctuating standardized uptake values.
AJR Am J Roentgenol
; 190(4): 1091-6, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18356460
4.
Pharmacokinetics and toxicity of weekly docetaxel in older patients.
Clin Cancer Res
; 12(20 Pt 1): 6100-5, 2006 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17062686
5.
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer.
Clin Breast Cancer
; 7(3): 270-7, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16942645
6.
Fentanyl Iontophoretic Transdermal System (IONSYS(®)) can be Safely used in the Hospital Environment with X-Rays, Computerized Tomography and Radiofrequency Identification Devices.
Adv Ther
; 33(9): 1649-59, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27423647
7.
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.
Clin Breast Cancer
; 11(5): 306-11, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21729667
8.
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.
J Clin Oncol
; 28(4): 628-33, 2010 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19841327
9.
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
J Clin Oncol
; 28(11): 1896-903, 2010 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20212248
10.
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.
Ann Surg Oncol
; 13(5): 677-84, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16538409